Literature DB >> 31583742

Atrial premature depolarisations five days post electrical cardioversion are related to atrial fibrillation recurrence risk in horses.

I Vernemmen1, D De Clercq1, A Decloedt1, L Vera1, G Van Steenkiste1, G van Loon1.   

Abstract

BACKGROUND: The number of atrial premature depolarisations (APDs) is a known risk factor for atrial fibrillation (AF) recurrence in humans.
OBJECTIVES: To evaluate if the number of APDs over a 24-h period 5 days post cardioversion predicts AF recurrence within 1 year in horses, taking the multifactorial nature of AF into account. STUDY
DESIGN: Retrospective case series.
METHODS: Eighty horses met these inclusion criteria: first AF episode, no AF recurrence within 5 days post cardioversion, cardioversion by transvenous electrical cardioversion (TVEC), 24-h ECG recording and echocardiographic examination 5 days post cardioversion, no antiarrhythmic treatment during the ECG recording and follow-up of minimum 1 year. To compare the APD burden between the recurrence and non-recurrence group a Mann-Whitney U test was used. A multivariable survival model was built to identify additional risk factors for AF recurrence.
RESULTS: The patient population mainly consisted of Warmbloods (93%). Twenty-six horses (33%) experienced AF recurrence within 1 year. The number of APDs (median [range]) was significantly higher (P = 0.01) in the recurrence group (15 [1-152]) compared with the non-recurrence group (7 [0-304]). In the multivariable survival model, APDs ≥25/24 h (hazard ratio [HR] 2.9, 95% confidence interval [CI] 1.2-6.8, P = 0.02), mitral regurgitation (HR 8.6, 95% CI 2.6-28.9, P<0.001), left atrial active fractional area change ≤9.6% (HR 2.6, 95% CI 1.0-6.5, P = 0.04) and lower body weight (HR 0.99, 95% CI 0.98-0.99, P = 0.001) were significantly associated with AF recurrence. MAIN LIMITATIONS: This study did not evaluate early AF recurrence within 5 days. The results cannot necessarily be extrapolated to other treatment methods, as only horses converted by TVEC were included.
CONCLUSIONS: The APD burden 5 days post cardioversion could be a useful predictive value for AF recurrence within 1 year in horses. However, other factors such as mitral regurgitation and atrial contractile function must also be taken into account.
© 2019 EVJ Ltd.

Entities:  

Keywords:  arrhythmias; atrial ectopy; electrocardiogram; horse; transvenous electrical cardioversion

Mesh:

Substances:

Year:  2019        PMID: 31583742     DOI: 10.1111/evj.13186

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  4 in total

1.  Incidence, recurrence, and outcome of postrace atrial fibrillation in Thoroughbred horses.

Authors:  Laura C Nath; Adrian D Elliott; Joe Weir; Peter Curl; Sarah M Rosanowski; Samantha Franklin
Journal:  J Vet Intern Med       Date:  2021-02-19       Impact factor: 3.333

2.  Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence.

Authors:  Ingrid Vernemmen; Glenn Van Steenkiste; Alexander Dufourni; Annelies Decloedt; Gunther van Loon
Journal:  J Vet Intern Med       Date:  2022-03-05       Impact factor: 3.333

3.  Increased fibroblast accumulation in the equine heart following persistent atrial fibrillation.

Authors:  Arnela Saljic; Merle Friederike Fenner; Joris Winters; Mette Flethøj; Caroline Eggert Eggertsen; Helena Carstensen; Sarah Dalgas Nissen; Eva Melis Hesselkilde; Arne van Hunnik; Ulrich Schotten; Ulrik Sørensen; Thomas Jespersen; Sander Verheule; Rikke Buhl
Journal:  Int J Cardiol Heart Vasc       Date:  2021-07-20

4.  Implantable loop recorders can detect paroxysmal atrial fibrillation in Standardbred racehorses with intermittent poor performance.

Authors:  Rikke Buhl; Sarah D Nissen; Marie L K Winther; Sofie K Poulsen; Charlotte Hopster-Iversen; Thomas Jespersen; Prashanthan Sanders; Helena Carstensen; Eva M Hesselkilde
Journal:  Equine Vet J       Date:  2020-11-23       Impact factor: 2.888

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.